Active Pharmaceutical Ingredients
Piroxicam Pellets are formulated for oral delivery of Piroxicam, a long-acting nonsteroidal anti-inflammatory drug (NSAID) commonly used in the treatment of rheumatoid arthritis, osteoarthritis, and other inflammatory conditions. These pellets utilize advanced multiparticulate technology to enable consistent drug release, enhanced absorption, and improved gastrointestinal tolerability. Suitable for once-daily formulations, they are ideal for use in capsules, tablets, or sachets.
| Component | Function |
|---|---|
| Piroxicam Pellets | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Pellets | Inert core |
| Hydroxypropyl Methylcellulose (HPMC) | Binder |
| Sodium Lauryl Sulfate (SLS) | Surfactant |
| Sodium Starch Glycolate | Superdisintegrant |
| Lactose | Filler / diluent |
| Simethicone Emulsion | Antifoaming agent |
| Methacrylic Acid–Ethyl Acrylate Copolymer (Eudragit L30D-55) | Enteric polymer |
| Triethyl Citrate | Plasticizer |
| Talc | Anti-adherent |
| Colloidal Silicon Dioxide | Glidant |
| Purified Water | Used in aqueous layering |
Salius Pharma’s Piroxicam Pellets are manufactured in USFDA-approved, WHO-GMP-certified facilities using advanced pelletization and controlled-release technologies. Our formulations offer excellent flow properties, uniform pellet size, and optimized drug release tailored to client specifications. With full regulatory support, customizable strengths, and a proven export track record, our pellets are ideal for finished dosage integration across regulated and emerging markets.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Piroxicam Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Piroxicam Granules are multiparticulate oral dosage forms designed for controlled or sustained release, ensuring consistent therapeutic effect. Their stability and standardized quality make them ideal for international shipment.
Yes. The granules are suitable for direct compression into tablets or capsule filling, providing flexibility for manufacturers while maintaining uniform drug content.
Salius Pharma offers custom drug loads, particle sizes, and release profiles, enabling manufacturers to meet specific regulatory and market requirements worldwide.
All batches are produced under GMP conditions, rigorously tested for stability, dissolution, and content uniformity, and shipped in export-grade packaging with complete regulatory documentation (CoA, MSDS, stability reports) for smooth international delivery.